Schnabel, R; Lubos, E; Rupprecht, HJ et al.
B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study.J Am Coll Cardiol. Bd. 47. 2006 S. 552-558
Kettering, K; Greil, GF; Busch, M et al.
Catheter ablation of atrial fibrillation: ongoing atrial fibrillation inside a single pulmonary vein after successful electrical disconnection and restoration of sinus rhythm in both atria.Clin Res Cardiol. Bd. 95. H. 12. 2006 S. 663-7
Blankenberg, S; McQueen, MJ; Smieja, M et al.
Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.Circulation. Bd. 114. H. 3. 2006 S. 201-8
Hink, U; Münzel, T
COX-2, another important player in the nitric oxide-endothelin cross-talk: good news for COX-2 inhibitors?Circ Res. Bd. 98. H. 11. 2006 S. 1344-1346
Kleschyov, AL; Strand, S; Schmitt, S et al.
Dinitrosyl-iron triggers apoptosis in Jurkat cells despite overexpression of Bcl-2Free Radical Bio Med. Bd. 40. H. 8. 2006 S. 1340-1348
Förstermann, U; Münzel, T
Endothelial nitric oxide synthase in vascular disease: from marvel to menace.Circulation. Bd. 113. H. 13. 2006 S. 1708-14
Wenzel, J; Lubos, E; Schnabel, R et al.
Evaluation of eNOS polymorphisms and the risk of future cardiovascular events in the AtheroGene studyEur Heart J. Bd. 27. 2006 S. 129 Suppl 1
Schnabel, R; Messow, CM; Lubos, E et al.
FLT-1 as an early diagnostic marker in acute coronary syndromes (Group Author(s): AtheroGene)Eur Heart J. Bd. 27. 2006 S. 152 Suppl 1
Schlitt, A; Blankenberg, S; Yan, D et al.
Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease.Nutr Metab Cardiovasc Dis. Bd. 3. 2006 S. 5
Morange, PE; Bickel, C; Nicaud, V et al.
Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease.Arterioscler Thromb Vasc Biol. Bd. 26. 2006 S. 2793-2799